Brief: Chabiotech receives U.S. patent
March 27 (Reuters) - Chabiotech Co Ltd 085660.KQ :
* Says it received U.S. patent on March 27, for a method for
producing cardiomyocytesfrom human or mouse embryonic stem
cellsin amedium consisting of aserum-free medium and N2
supplement
* Patent number is 13/907,967
Source text in Korean : https://goo.gl/dyb6cd
Further company coverage: 085660.KQ
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Chabiotech
See all newsBrief: Cha Biotech To Conduct Capital Increase Of 250 Billion Won
Brief: Chabiotech to buy properties for 16.95 bln won
Brief: Chabiotech says conversion of 4th series convertible bonds into shares
Brief: Chabiotech to divest biotechnology and medicine and medical supplies as well as retail business into new subsidiary
Brief: Chabiotech says conversion of 4th series convertible bonds into shares